Community Health Systems Inc: Form 10-Q for the period ended Sep 30, 2024
Filed with the SEC on Oct 24, 2024 and accepted by EDGAR at Oct 24, 2024, 16:34 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-07-01 to 2024-09-30 | $3.09bn | us-gaap:Revenues |
| Revenue | 9 months2024-01-01 to 2024-09-30 | $9.37bn | us-gaap:Revenues |
| Cost of revenue | 3 months2024-07-01 to 2024-09-30 | $469.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-01-01 to 2024-09-30 | $1.44bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months2024-07-01 to 2024-09-30 | −$205.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-01-01 to 2024-09-30 | $264.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-07-01 to 2024-09-30 | −$64.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-01-01 to 2024-09-30 | −$13.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-07-01 to 2024-09-30 | −$391.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-01-01 to 2024-09-30 | −$446.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-07-01 to 2024-09-30 | −$2.95 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-01-01 to 2024-09-30 | −$3.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-07-01 to 2024-09-30 | −$2.95 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-01-01 to 2024-09-30 | −$3.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-07-01 to 2024-09-30 | 132,376,226 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-01-01 to 2024-09-30 | 131,998,973 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-01-01 to 2024-09-30 | $264.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-01-01 to 2024-09-30 | $251.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-09-30 | $33.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-30 | $3.11bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-30 | $13.90bn | us-gaap:Assets |
| Current liabilities | At period end2024-09-30 | $2.13bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-09-30 | $15.18bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-09-30 | $11.47bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2024-09-30 | −$1.82bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-117088. Last ingested by Listed: Oct 29, 2026, 18:46 ET. Listed shows no prices and gives no investment advice.